Australia markets closed

TScan Therapeutics, Inc. (TCRX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
7.50+0.24 (+3.31%)
As of 02:03PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4454
Avg. Estimate-0.26-0.25-1.04-1.14
Low estimate-0.27-0.27-1.11-1.18
High estimate-0.24-0.23-0.98-1.08
Year ago EPS-0.93-0.51-1.36-1.04
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4444
Avg. Estimate3.97M4.07M16.51M11.37M
Low estimate2.5M2.5M10MN/A
High estimate5.4M5.51M22.5M21.98M
Year ago sales6.8M3.15M21.05M16.51M
Sales growth (year/est)-41.60%29.30%-21.60%-31.10%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.74-0.78-0.45-0.29
Actual EPS-0.93-0.51-0.24-0.21
Difference-0.190.270.210.08
Surprise %-25.70%34.60%46.70%27.60%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.26-0.25-1.04-1.14
7 days ago-0.25-0.26-1.05-1.11
30 days ago-0.25-0.26-1.05-1.11
60 days ago-0.26-0.27-1.2-1.15
90 days ago-0.26-0.27-1.2-1.15
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/A11N/A
Up last 30 daysN/A11N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1N/AN/A1
Growth estimatesTCRXIndustrySector(s)S&P 500
Current qtr.72.00%N/AN/AN/A
Next qtr.51.00%N/AN/AN/A
Current year23.50%N/AN/AN/A
Next year-9.60%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A